MarketLens

What's Driving Phathom Pharmaceuticals' Recent Momentum

5 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What's Driving IXICO's Recent Momentum

2 months ago

What's Driving Terns Pharmaceuticals' Recent Surge

4 months ago

What's Driving Junshi Biosciences' Recent Momentum

2 months ago

What's Driving Exelixis' Recent Momentum and 2026 Outlook

3 months ago

Phathom Pharmaceuticals Q2 Earnings Call Highlights

Phathom Pharmaceuticals reported Q2 2026 revenue growth of 88% YoY and achieved positive operating profit (excl. stock-based compensation) one quarter ahead of plan.

PHAT

Stock News•1 months ago

Here's Why Pharvaris N.V. (PHVS) is a Great Momentum Stock to Buy

Pharvaris N.V. (PHVS) is highlighted as a strong momentum stock, driven by positive clinical data for its HAE treatment deucrictibant and a favorable risk/reward profile ahead of Phase 3 results.

PHVS

Stock News•3 months ago

How Nanobiotix Got Wall Street's Attention By Using Physics To Battle Cancer

Nanobiotix is gaining investor attention as it attempts to modernize traditional cancer treatment methods using physics-based technology. The biotech firm's stock has experienced significant upward mo...

NBTX

Stock News•3 months ago

Why Agios Pharmaceuticals Stock Zoomed to a 13% Gain on Wednesday

Agios Pharmaceuticals shares rose 13% on Wednesday, driven by investor optimism surrounding the clinical potential of the company's lead molecule. The rally reflects market confidence in the asset's v...

AGIO